Nomura Holdings’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-22,700
| Closed | -$338K | – | 1206 |
|
|
2025
Q1 | $338K | Buy |
+22,700
| New | +$338K | ﹤0.01% | 890 |
|
|
2024
Q4 | – | Sell |
-25,000
| Closed | -$356K | – | 1678 |
|
|
2024
Q3 | $356K | Buy |
+25,000
| New | +$356K | ﹤0.01% | 723 |
|
|
2024
Q2 | – | Sell |
-16,800
| Closed | -$233K | – | 1317 |
|
|
2024
Q1 | $233K | Sell |
16,800
-190,800
| -92% | -$2.65M | ﹤0.01% | 803 |
|
|
2023
Q4 | $2.96M | Buy |
+207,600
| New | +$2.96M | 0.01% | 391 |
|
|
2023
Q3 | – | Sell |
-364,302
| Closed | -$5.72M | – | 1056 |
|
|
2023
Q2 | $5.72M | Buy |
+364,302
| New | +$5.72M | 0.02% | 176 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 1156 |
|
|
2022
Q4 | – | Sell |
-128,600
| Closed | -$1.67M | – | 1211 |
|
|
2022
Q3 | $1.67M | Buy |
+128,600
| New | +$1.67M | 0.01% | 491 |
|
|
2021
Q1 | – | Sell |
-215,000
| Closed | -$3.91M | – | 1726 |
|
|
2020
Q4 | $3.91M | Buy |
215,000
+130,000
| +153% | +$2.36M | 0.01% | 395 |
|
|
2020
Q3 | $1.52M | Buy |
85,000
+17,500
| +26% | +$314K | ﹤0.01% | 449 |
|
|
2020
Q2 | $1.22M | Sell |
67,500
-35,000
| -34% | -$631K | ﹤0.01% | 433 |
|
|
2020
Q1 | $1.55M | Sell |
102,500
-17,500
| -15% | -$265K | 0.01% | 291 |
|
|
2019
Q4 | $2.37M | Sell |
120,000
-165,000
| -58% | -$3.26M | 0.01% | 337 |
|
|
2019
Q3 | $4.94M | Hold |
285,000
| – | – | 0.02% | 255 |
|
|
2019
Q2 | $5.04M | Sell |
285,000
-117,500
| -29% | -$2.08M | 0.02% | 269 |
|
|
2019
Q1 | $8.25M | Buy |
+402,500
| New | +$8.25M | 0.03% | 207 |
|